Position in CYTK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,142,312
+$46,163 QoQ
Shares Held
13,409
-19.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#250
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. CYTK ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,142,312 | 13,409 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,096,149 | 16,631 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $884,032 | 13,913 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $703,488 | 12,800 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $344,375 | 10,423 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $456,236 | 11,352 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $438,553 | 9,323 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $570,451 | 10,804 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $587,907 | 10,851 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $704,885 | 10,054 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $786,308 | 9,418 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $261,251 | 8,868 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $275,117 | 8,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $287,220 | 8,162 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $373,982 | 8,162 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $492,978 | 10,175 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $400,522 | 10,194 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $375,756 | 10,208 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $460,585 | 10,105 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $358,507 | 10,031 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $197,900 | 10,000 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $279,120 | 12,000 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $263,906 | 12,700 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $274,955 | 12,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $299,339 | 12,700 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $149,733 | 12,700 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||